Literature DB >> 22013121

Containing the contagion: treating the virus that inspired the film.

Benhur Lee1.   

Abstract

Postexposure passive immunotherapy protects African green monkeys from lethal challenge with Contagion-related Hendra virus.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22013121      PMCID： PMC3345275          DOI： 10.1126/scitranslmed.3003245

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  10 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.

Authors:  Katharine N Bossart; Thomas W Geisbert; Heinz Feldmann; Zhongyu Zhu; Friederike Feldmann; Joan B Geisbert; Lianying Yan; Yan-Ru Feng; Doug Brining; Dana Scott; Yanping Wang; Antony S Dimitrov; Julie Callison; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Christopher C Broder; Barry Rockx
Journal:  Sci Transl Med       Date:  2011-10-19       Impact factor: 17.956

3.  A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Authors:  Katharine N Bossart; Zhongyu Zhu; Deborah Middleton; Jessica Klippel; Gary Crameri; John Bingham; Jennifer A McEachern; Diane Green; Timothy J Hancock; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Lin-Fa Wang; Christopher C Broder
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

4.  Transmission of human infection with Nipah virus.

Authors:  Stephen P Luby; Emily S Gurley; M Jahangir Hossain
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

5.  Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.

Authors:  Oscar A Negrete; David Chu; Hector C Aguilar; Benhur Lee
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

6.  Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.

Authors:  R Malley; J DeVincenzo; O Ramilo; P H Dennehy; H C Meissner; W C Gruber; P J Sanchez; H Jafri; J Balsley; D Carlin; S Buckingham; L Vernacchio; D M Ambrosino
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

7.  Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.

Authors:  Wendelien B Oswald; Thomas W Geisbert; Kelly J Davis; Joan B Geisbert; Nancy J Sullivan; Peter B Jahrling; Paul W H I Parren; Dennis R Burton
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

Review 8.  Hendra and Nipah viruses: different and dangerous.

Authors:  Bryan T Eaton; Christopher C Broder; Deborah Middleton; Lin-Fa Wang
Journal:  Nat Rev Microbiol       Date:  2006-01       Impact factor: 60.633

Review 9.  Monoclonal antibody-based therapies for microbial diseases.

Authors:  Carolyn Saylor; Ekaterina Dadachova; Arturo Casadevall
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

10.  Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.

Authors:  Zhongyu Zhu; Katharine N Bossart; Kimberly A Bishop; Gary Crameri; Antony S Dimitrov; Jennifer A McEachern; Yang Feng; Deborah Middleton; Lin-Fa Wang; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226
  10 in total
  2 in total

1.  Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates.

Authors:  Cyrille Mathieu; Matteo Porotto; Tiago N Figueira; Branka Horvat; Anne Moscona
Journal:  J Infect Dis       Date:  2018-06-20       Impact factor: 5.226

Review 2.  Human monoclonal antibodies as candidate therapeutics against emerging viruses.

Authors:  Yujia Jin; Cheng Lei; Dan Hu; Dimiter S Dimitrov; Tianlei Ying
Journal:  Front Med       Date:  2017-11-20       Impact factor: 4.592
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.